Osteoporosis in ankylosing spondylitis

被引:0
作者
Bhargava, Pavan [2 ]
Danda, Debashish [1 ]
机构
[1] Christian Med Coll & Hosp, Dept Rheumatol & Clin Immunol, Vellore 632004, Tamil Nadu, India
[2] Christian Med Coll & Hosp, Dept Med, Vellore 632004, Tamil Nadu, India
关键词
ankylosing spondylitis; bone mineral density; fracture; osteoporosis;
D O I
10.1111/j.1756-185X.2008.00394.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ankylosing spondylitis (AS) is a chronic inflammatory disorder, characterized by an inflammatory enthesopathy progressing to ossification and ankylosis. Osteoporosis is a well-reported complication of AS. Bone loss begins early in the disease at the spine, and later progresses to the hip. This reduction in bone density leads to an increased risk of fractures. However, there is a lack of awareness regarding this common complication, thus adding to the morbidity associated with AS. Early recognition, appropriate assessment and timely treatment of this complication will help reduce the attendant fracture risk due to decreased bone mass.
引用
收藏
页码:374 / 380
页数:7
相关论文
共 50 条
  • [31] Utility of DXA scanning and risk factors for osteoporosis in ankylosing spondylitis-A prospective study
    Magrey, Marina N.
    Lewis, Steven
    Khan, Muhammad Asim
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 46 (01) : 88 - 94
  • [32] Is osteoporosis generalized or localized to central skele-ton in ankylosing spondylitis?
    Sarikaya, Selda
    Basaran, Aynur
    Tekin, Yasin
    Ozdolap, Senay
    Ortancil, Ozgur
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2007, 13 (01) : 20 - 24
  • [33] Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
    Torres, L.
    Klingberg, E.
    Nurkkala, M.
    Carlsten, H.
    Forsblad-d'Elia, H.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (02) : 441 - 449
  • [34] Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
    L. Torres
    E. Klingberg
    M. Nurkkala
    H. Carlsten
    H. Forsblad-d’Elia
    Osteoporosis International, 2019, 30 : 441 - 449
  • [35] Changes in bone mineral density and bone metabolic indexes in ankylosing spondylitis mouse model complicated with osteoporosis
    Hu, Zi-Bing
    Wei, Bo
    Wu, Shao-Ke
    Sun, Jie-Cong
    Xiang, Min
    Zhang, Zhong-Min
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (02) : 811 - 815
  • [36] Computational Drug Discovery in Ankylosing Spondylitis-Induced Osteoporosis Based on Data Mining and Bioinformatics Analysis
    Wang, Chenfeng
    Wang, Liang
    Li, Qisheng
    Wu, Weiqing
    Yuan, Jincan
    Wang, Haibin
    Lu, Xuhua
    WORLD NEUROSURGERY, 2023, 174 : E8 - E16
  • [37] The relationship between bath indexes and osteoporosis in male patients with axial ankylosing spondylitis
    Karapolat, Hale
    Eyigoer, Sibel
    Akkoc, Yesim
    Kirazli, Yesim
    Sari, Ismail
    Akar, Servet
    Akkoc, Nurullah
    ROMATIZMA-RHEUMATISM, 2008, 23 (03): : 82 - 86
  • [38] Male osteoporosis with vertebral fractures?: Look for ankylosing spondylitis!: A report of 10 cases
    Laroche, Michel
    Lassoued, Slim
    Billey, Thierry
    Bernard, Jacques
    Mazieres, Bernard
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (11) : 2271 - 2272
  • [39] The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis
    Bedriye Mermerci Başkan
    Yasemin Pekin Doğan
    Filiz Sivas
    Hatice Bodur
    Kürşat Özoran
    Rheumatology International, 2010, 30 : 375 - 381
  • [40] Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment
    Klingberg, Eva
    Lorentzon, Mattias
    Mellstrom, Dan
    Geijer, Mats
    Gothlin, Jan
    Hilme, Elisabet
    Hedberg, Martin
    Carlsten, Hans
    Forsblad-d'Elia, Helena
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (03)